Generation and Characterization of a genetic zebrafish model of SMA carrying the human SMN2 gene

被引:36
|
作者
Hao, Le T. [1 ,2 ]
Burghes, Arthur H. M. [3 ]
Beattie, Christine E. [1 ,2 ]
机构
[1] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
来源
MOLECULAR NEURODEGENERATION | 2011年 / 6卷
关键词
SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MOUSE MODEL; NEUROMUSCULAR-JUNCTIONS; TRANSGENIC ZEBRAFISH; SINGLE NUCLEOTIDE; AXON OUTGROWTH; PROTEIN; MICE; IDENTIFICATION;
D O I
10.1186/1750-1326-6-24
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Animal models of human diseases are essential as they allow analysis of the disease process at the cellular level and can advance therapeutics by serving as a tool for drug screening and target validation. Here we report the development of a complete genetic model of spinal muscular atrophy (SMA) in the vertebrate zebrafish to complement existing zebrafish, mouse, and invertebrate models and show its utility for testing compounds that alter SMN2 splicing. Results: The human motoneuron disease SMA is caused by low levels, as opposed to a complete absence, of the survival motor neuron protein (SMN). To generate a true model of SMA in zebrafish, we have generated a transgenic zebrafish expressing the human SMN2 gene (hSMN2), which produces only a low amount of full-length SMN, and crossed this onto the smn(-/-) background. We show that human SMN2 is spliced in zebrafish as it is in humans and makes low levels of SMN protein. Moreover, we show that an antisense oligonucleotide that enhances correct hSMN2 splicing increases full-length hSMN RNA in this model. When we placed this transgene on the smn mutant background it rescued the neuromuscular presynaptic SV2 defect that occurs in smn mutants and increased their survival. Conclusions: We have generated a transgenic fish carrying the human hSMN2 gene. This gene is spliced in fish as it is in humans and mice suggesting a conserved splicing mechanism in these vertebrates. Moreover, antisense targeting of an intronic splicing silencer site increased the amount of full length SMN generated from this transgene. Having this transgene on the smn mutant fish rescued the presynaptic defect and increased survival. This model of zebrafish SMA has all of the components of human SMA and can thus be used to understand motoneuron dysfunction in SMA, can be used as an vivo test for drugs or antisense approaches that increase full-length SMN, and can be developed for drug screening.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Rescue of gene-expression changes in an induced mouse model of spinal muscular atrophy by an antisense oligonucleotide that promotes inclusion of SMN2 exon 7
    Staropoli, John F.
    Li, Huo
    Chun, Seung J.
    Allaire, Norm
    Cullen, Patrick
    Thai, Alice
    Fleet, Christina M.
    Hua, Yimin
    Bennett, C. Frank
    Krainer, Adrian R.
    Kerr, Doug
    McCampbell, Alexander
    Rigo, Frank
    Carulli, John P.
    GENOMICS, 2015, 105 (04) : 220 - 228
  • [22] Development of 2′-O-Methyl and LNA Antisense Oligonucleotides for SMN2 Splicing Correction in SMA Cells
    Maretina, Marianna
    Il'ina, Arina
    Egorova, Anna
    Glotov, Andrey
    Kiselev, Anton
    BIOMEDICINES, 2023, 11 (11)
  • [23] Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR
    Stabley, Deborah L.
    Holbrook, Jennifer
    Scavina, Mena
    Crawford, Thomas O.
    Swoboda, Kathryn J.
    Robbins, Katherine M.
    Butchbach, Matthew E. R.
    NEUROGENETICS, 2021, 22 (01) : 53 - 64
  • [24] Improvement of TaC9-ABE mediated correction of human SMN2 gene
    Peng, Xiaohua
    Chi, Yue
    Wang, Jinling
    Li, Shuangpeng
    Liu, Yang
    Tang, Chengcheng
    Zhou, Xiaoqing
    Lu, Xuan
    Gao, Yue
    Lai, Liangxue
    Chen, Min
    Zou, Qingjian
    BIOTECHNOLOGY AND BIOENGINEERING, 2024, 121 (10) : 3059 - 3067
  • [25] A SMN2 Splicing Modifier Rescues the Disease Phenotypes in an In Vitro Human Spinal Muscular Atrophy Model
    Son, Ye Seul
    Choi, Kwangman
    Lee, Hana
    Kwon, Ohman
    Jung, Kwang Bo
    Cho, Sunwha
    Baek, Jiyeon
    Son, Bora
    Kang, Sung-Min
    Kang, Mingu
    Yoon, Jihee
    Shen, Haihong
    Lee, Sangku
    Oh, Jung-Hwa
    Lee, Hyang-Ae
    Lee, Mi-Ok
    Cho, Hyun-Soo
    Jung, Cho-Rok
    Kim, Janghwan
    Cho, Sungchan
    Son, Mi-Young
    STEM CELLS AND DEVELOPMENT, 2019, 28 (07) : 438 - 453
  • [26] A Cell System for Phenotypic Screening of Modifiers of SMN2 Gene Expression and Function
    Li, Darrick K.
    Tisdale, Sarah
    Espinoza-Derout, Jorge
    Saieva, Luciano
    Lotti, Francesco
    Pellizzoni, Livio
    PLOS ONE, 2013, 8 (08):
  • [27] Differential regulation of the SMN2 gene by individual HDAC proteins
    Evans, Matthew C.
    Cherry, Jonathan J.
    Androphy, Elliot J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 414 (01) : 25 - 30
  • [28] Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1
    Shuji Ogino
    Sizhen Gao
    Debra G B Leonard
    Michele Paessler
    Robert B Wilson
    European Journal of Human Genetics, 2003, 11 : 275 - 277
  • [29] Inverse correlation between SMN1 and SMN2 copy numbers:: evidence for gene conversion from SMN2 to SMN1
    Ogino, S
    Gao, SZ
    Leonard, DGB
    Paessler, M
    Wilson, RB
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (03) : 275 - 277
  • [30] Reduced Survival of Motor Neuron (SMN) Protein in Motor Neuronal Progenitors Functions Cell Autonomously to Cause Spinal Muscular Atrophy in Model Mice Expressing the Human Centromeric (SMN2) Gene
    Park, Gyu-Hwan
    Maeno-Hikichi, Yuka
    Awano, Tomoyuki
    Landmesser, Lynn T.
    Monani, Umrao R.
    JOURNAL OF NEUROSCIENCE, 2010, 30 (36) : 12005 - 12019